CILP2 and hyperlipidemia: In their study the SNP rs16996148 (CILP2) decreased the risk of hyperlipidemia, whereas rs16996148 GT/TT and diabetes mellitus as well as rs16996148 TT and diabetes mellitus increased the risk of hyperlipidemia29.